2025-05-11 - Analysis Report
## Air Products and Chemicals Inc. (APD) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (APD):** 39.09%
* **Cumulative Return (VOO):** 87.98%
* **Return Difference (APD vs VOO):** -48.9%
* **Relative Divergence:** 15.6% (This means APD's performance relative to VOO is at the 15.6th percentile of its historical range of divergence.)
* **Current Price:** $269.64
* **5-day Moving Average:** $270.34
* **20-day Moving Average:** $267.61
* **60-day Moving Average:** $287.33
* **RSI:** 57.00
* **PPO:** 0.46
* **Market Risk Indicator (MRI):** 0.37 (Medium Risk)
* **Expected Return (vs. S&P 500, long-term):** -47.0%


**1. Company Overview and Performance Comparison:**

Air Products and Chemicals Inc. is a leading industrial gases company.  The cumulative return of APD (39.09%) significantly underperforms the S&P 500 (VOO) with a cumulative return of 87.98%, resulting in a difference of -48.9%.  The relative divergence of 15.6% suggests that while APD's underperformance is substantial, it's not entirely unprecedented within the historical context of its performance relative to the S&P 500.

The Alpha and Beta analysis shows varying performance depending on the period examined. While some periods show positive alpha (outperformance relative to the market), recent years (2021-2025) indicate negative CAGR and high negative alpha, highlighting significant underperformance against the market. The Beta generally stays around 0.8, suggesting moderate volatility relative to the market.


**2. Recent Price Movement:**

The current closing price is slightly below the 5-day moving average and above the 20-day moving average, suggesting a recent slight dip in price.  However, it's significantly below the 60-day moving average, indicative of a longer-term downtrend. The last market data shows a small price increase ($0.55).


**3. Technical Indicators and Expected Return:**

The RSI of 57 suggests the stock is neither overbought nor oversold. The PPO of 0.46 indicates a potential bullish signal. The recent relative divergence of -3.1 suggests a short-term downward trend. Given the relatively low market risk indicator (MRI) of 0.37, the market risk associated with the current price appears moderate.  The expected return of -47% over the long term (2+ years) compared to the S&P 500 is a substantial negative projection.

**4. Recent Earnings Analysis:**

The recent earnings data shows some volatility in EPS, with a significant negative EPS reported in May 2025 (-7.77).  Revenue remains relatively stable around $2.9B - $3.0B.  The inconsistent EPS figures warrant further investigation into the underlying causes for this volatility.  There's a possible data entry error in the provided table as May 2025 shows two different EPS values.



| Date       | EPS   | Revenue      |
|------------|-------|--------------|
| 2025-05-01 | -7.77 | $2.92B       |
| 2025-02-06 | 2.77  | $2.93B       |
| 2024-08-01 | 3.13  | $2.99B       |
| 2024-04-30 | 2.57  | $2.93B       |
| 2025-05-01 | 2.57  | $2.93B       |


**5. Financial Information:**

Revenue has been relatively stable, though Q3 2024 showed a higher figure. Profit margins have generally been high (above 30%) but show some decline in recent quarters.  The ROE is volatile, with a significant negative value in Q1 2025 (-11.77%), suggesting potential challenges.  Equity has generally increased, except for a dip in Q1 2025. The large drop in ROE for Q1 2025 needs further investigation.



| Quarter    | Revenue    | Profit Margin | Equity    | ROE       |
|------------|------------|---------------|------------|-----------|
| 2025-03-31 | $2.92B     | 29.57%        | $14.70B   | -11.77%   |
| 2024-12-31 | $2.93B     | 31.21%        | $16.69B   | 3.70%     |
| 2024-09-30 | $3.19B     | 33.98%        | $17.04B   | 11.45%    |
| 2024-06-30 | $2.99B     | 32.82%        | $15.10B   | 4.61%     |
| 2024-03-31 | $2.93B     | 32.04%        | $14.91B   | 3.84%     |


**6. Overall Analysis:**

APD has significantly underperformed the S&P 500 in recent years, with a projected long-term negative return compared to the market. While some periods have shown positive alpha, recent financial results (particularly the Q1 2025 earnings and ROE) raise concerns. The negative EPS and drop in ROE are major warning signs. Further investigation into the reasons for these results is crucial before making any investment decisions. The relatively stable revenue and generally high profit margins offer some counterpoint, but the negative outlook outweighs the positives based on the presented data.  More comprehensive due diligence is needed before considering an investment.  The large negative expected return in comparison to the S&P 500 makes a long-term investment look extremely unattractive at this time.
